Medical cannabis related reduction of other medications Canada 2020

Based on a survey conducted in July-August 2020, this statistic illustrates the reduced use of other medications through increased medical cannabis use among adult Canadian patients, by medical document status. Around 40 percent of respondents reported a decrease in anti-inflammatory use, regardless of whether they had a medical document or not. In Canada, a medical document from a healthcare professional is required to purchase medical cannabis from a licensed producer.

Percentage of Canadian patients who reduced the use of other medications through increased cannabis use as of 2020

Characteristic	With medical document	Without medical document
Anti-inflammatories	41%	41%
Opioid pain relievers	33%	18%
Non-opioid pain relievers	32%	27%
Anti-depressants	27%	22%
Sedatives/tranquilizers	22%	18%
Other	3%	4%
No reduction in other medications	24%	32%

Loading statistic...

Download

Source

Show detailed source information?

Already a member?

Sources

Use Ask Statista Research Service

Release date

October 2020

More information

Region

Canada

Survey time period

July 20 to August 1, 2020

Number of respondents

1,000 respondents

Age group

18 years and older

Special properties

medical cannabis patients

Supplementary notes

Original question: "Have you been able to reduce the use of any of the following types of medications you previously used, through increased cannabis use? Please select all that apply."

Citation formats